Migraine
📧 Sign up to get email alerts when something new happens for Migraine.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: Follow-up of Migraine Patients on Eptinezumab
Follow-up update from a completed study evaluating eptinezumab in migraine patients.
-
CLINICAL_TRIALS research · 2024-11-01Clinical Trial Update: Quest to Analyze One Thousand Humans Meditating
A ClinicalTrials.gov update indicates a study is enrolling up to 1,000 participants to assess the effects of meditation across multiple cond…
-
FDA approval · 2024-10-31FDA Approved: BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Actavis's fixed-dose combination analgesic Butalbital, Acetaminophen, Caffeine, and Codeine Phos…
-
FDA approval · 2024-10-31FDA Approved: FIORICET WITH CODEINE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved Actavis Pharma, Inc.'s supplemental application for Fioricet with Codeine (butalbital, acetaminophen, caffeine, and codeine…
-
FDA approval · 2024-10-31FDA Approved: TOPIRAMATE — Original Application (Ascend Laboratories, LLC)
The FDA approved Ascend Laboratories' original ANDA for topiramate, providing a generic version of this anticonvulsant and migraine preventi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-10-30Clinical Trial Update: Ultrasound Guided Block of Stellate Ganglion Versus Greater Occipital Nerve in Resistant Migraine and Correlation to Calcitonin Gene Related Peptide [NA]
This clinical trial compares ultrasound-guided stellate ganglion block to greater occipital nerve block for resistant migraine and examines …
-
CLINICAL_TRIALS research · 2024-10-28Clinical Trial Update: Migraine Attack Treatment Response Molecular and Clinical BiOmarkers (MAMBO) Phase I
This entry describes a Phase I clinical trial (MAMBO) evaluating molecular and clinical biomarkers for migraine attack treatment response, w…
-
FDA approval · 2024-10-23FDA Approved: TOPIRAMATE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for Topiramate from Zydus Lifesciences Limited under an ANDA.
-
CLINICAL_TRIALS research · 2024-10-22Clinical Trial Update: Relieving Chronic Pain: Psychosomatic Mechanisms and Psychological Interventions in Fibromyalgia and Chronic Headache [NA]
The trial, sponsored by the University of Rome La Sapienza, investigates psychosomatic mechanisms and psychological interventions for chroni…
-
CLINICAL_TRIALS research · 2024-10-17Clinical Trial Update: The Impact of Greater Occipital Nerve and Stellate Ganglion Block Treatments on Sleep in Chronic Headache Management [NA]
A clinical trial update from Ankara Etlik City Hospital evaluating greater occipital nerve block and stellate ganglion block for sleep in ch…
-
EMA approval · 2024-10-16EMA Authorised: Vyepti (Eptinezumab) — H. Lundbeck A/S
The European Medicines Agency has authorised Vyepti (eptinezumab) by H. Lundbeck A/S for migraine disorders.
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Expectancies in Migraine Patients [NA]
A migraine-focused clinical trial sponsored by the University of Florence has completed. The snippet provides limited detail about results.
-
CLINICAL_TRIALS trial_result · 2024-10-09Clinical Trial Update: BIOMIGA: Results from Magnetic Resonance Imaging
This update reports MRI results from the BIOMIGA clinical trial in migraine patients.
-
CLINICAL_TRIALS research · 2024-10-09Clinical Trial Update: Impact of Combined Oral Contraceptive Pills on Migraine [Phase 4]
Phase 4 clinical trial evaluating the impact of combined oral contraceptive pills on migraine. The study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Study to Assess Adverse Events When Ubrogepant Tablets in Combination With Atogepant Tablets Are Used to Treat Adult Participants With Migraine [Phase 4]
Phase 4 trial update evaluating adverse events when ubrogepant is used in combination with atogepant to treat episodic migraine in adults; r…
-
CLINICAL_TRIALS trial_result · 2024-10-02Clinical Trial Update: Efficacy of Zolmitriptan (Zomig) in the Treatment of Migraines in Adolescents [Phase 3]
Phase 3 trial results assess the efficacy of Zolmitriptan (Zomig) for treating migraines in adolescents; the study has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: Magnesium Versus Prochlorperazine Versus Metoclopramide for Migraines [Phase 3]
Phase 3 clinical trial comparing magnesium with prochlorperazine and metoclopramide for migraine treatment has completed and posted results.
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: German Translation and Cross-cultural Adaptation of the Headache Screening Questionnaire (HSQ) Followed by a Test-retest Reliability Study. [NA]
This clinical trial update reports the German translation and cross-cultural adaptation of the Headache Screening Questionnaire (HSQ) and a …
-
CLINICAL_TRIALS trial_result · 2024-09-26Clinical Trial Update: Mi-Helper Transnasal Cooling for Acute Treatment of Migraine [NA]
This clinical trial update reports the completed study evaluating Mi-Helper Transnasal Cooling for acute treatment of migraine (including mi…
-
CLINICAL_TRIALS trial_result · 2024-09-20Clinical Trial Update: Extension Study of ABP-20001 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 for Migraine Prevention [Phase 2]
A Phase 2 extension study to evaluate the safety and efficacy of repeat ABP-450 injections for migraine prevention has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine [Phase 4]
A Phase 4 clinical trial update reports results on patient treatment satisfaction with erenumab for migraine; the study has completed and re…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: TelemEdiciNe-bAsed Cognitive TherapY for Migraines [NA]
A telemedicine-based cognitive therapy trial for migraine has completed, with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Pain Control in Episodic and Chronic Migraine [NA]
A completed clinical trial investigates pain control in episodic and chronic migraine.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: OnaBotulinumtoxin-A in Chronic Migraine Patients With Short or Long Disease History (the BACH Study)
This clinical trial update describes an ongoing study evaluating onabotulinumtoxinA (Botox) for chronic migraine, comparing outcomes in pati…
-
CLINICAL_TRIALS withdrawal · 2024-09-19Clinical Trial Update: Onabotulinum Toxin A (Botox) for the Treatment of Persistent Post-Stroke and Vascular Headache [Phase 1]
A Phase 1 trial evaluating Onabotulinumtoxin A (Botox) for persistent post-stroke and vascular headache was withdrawn.